Zhao et al. 2023; observed treatment of first-episode schizophrenia patients with risperidone for a period of two weeks, led to a significant increase in the BDNF levels along with a decrease in psychotic symptoms (Zhao et al. 2023). Here, BDNF is linked to schizophrenia.